Newsroom | 5366 results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced its preliminary, unaudited net sales for the fourth quarter and full year ended December 31, 2025, and reaffirmed its full year 2026 revenue guidance. Preliminary and unaudited total net sales for the fourth quarter of 2025 are expected to be approximately $14...

CAMBRIDGE, England & EDINBURGH, Scotland--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 million (£2.1 million) in funding. The investment was led by US life sciences specialist BroadOak Capital Partners, with the company’s founding investor, the Roslin Foundation, also participating. The funding will accelerate Axol’s next phase of growth, sup...

CENTENNIAL, Colo.--(BUSINESS WIRE)--Arrow Electronics collaborates with Romanian startup .lumen on AI glasses that replicate the key functions of a guide dog on a wearable headset....

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reaffirmed its fiscal 2025 outlook ahead of its participation at the 2026 ICR Conference. The Company reaffirms its fiscal 2025 outlook for the 53 weeks ending January 3, 2026, as set forth below. New Stores: ~32 Adjusted Comparable Store Sales Growth(1)(2): 5.0% - 6.0% Net Revenue: $1.970 billion - $1.988 billion(3) Adjusted Operating Income(2)(3): $92 million - $98 million Adj...

ROCHDALE, United Kingdom--(BUSINESS WIRE)--Astoriom today announced the appointment of Will Edwards, MBA as CEO to support global scale-up of sample management operations....

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™...

BOCA RATON, Fla.--(BUSINESS WIRE)--Il Cataltheia Group e la sua controllata, Bruno Vision Care LLC, azienda leader nell'innovazione della salute degli occhi, oggi ha annunciato che la Food and Drug Administration (FDA) statunitense ha approvato la prima e unica lente a contatto morbida per la presbiopia che utilizza la tecnologia brevettata di progettazione ottica Extended Depth of Focus (EDOF), dando il via alla distribuzione commerciale negli Stati Uniti. Deseyne® offre una focalizzazione flu...

BOSTON--(BUSINESS WIRE)--Diorasis Therapeutics, a Boston-based biotechnology company developing durable gene therapies for glaucoma and other ophthalmic diseases, today announced the appointment of Richard A. Kresch, MD, to its Board of Directors. Dr. Kresch is a veteran healthcare executive and multi-time founder with more than 30 years of experience building, financing, and scaling provider businesses. He is Founder and Chief Executive Officer of US HealthVest, a network of behavioral health...

PARIJS--(BUSINESS WIRE)--Abbelight, een wereldleider en pionier in end-to-end oplossingen voor super-resolutiemicroscopie, kondigde vandaag een succesvolle Serie B-financieringsronde aan, geleid door AVANT BIO, een verstrekker van groeikapitaal die zich toelegt op sleuteltechnologieën die therapeutica van morgen vorm geven. “Met tien jaar ervaring in de markt van biowetenschappenonderzoek, heeft Abbelight de manier veranderd waarop wetenschappers allerlei soorten complexe intracellulaire mechan...

PARIS--(BUSINESS WIRE)--Abbelight, ein Weltmarktführer und Pionier im Bereich End-to-End-Lösungen für die Superauflösungsmikroskopie, gab heute den erfolgreichen Abschluss einer Serie-B-Finanzierungsrunde unter der Leitung von AVANT BIO bekannt, einer Wachstumskapitalgesellschaft, deren Schwerpunkt auf Technologien liegt, die die Therapeutika von morgen prägen werden. „Abbelight kann auf ein Jahrzehnt Erfahrung auf dem Markt für Life-Science-Forschung zurückblicken und hat die Art und Weise, wi...